Neurophysiology

🧠 Neural Signal Architecture: The Brain's Electrical Engineering

Your brain orchestrates every thought, movement, and sensation through precisely timed electrical and chemical signals traveling across billions of neurons. In this lesson, you'll decode how neurons generate and propagate action potentials, integrate synaptic inputs, and synchronize into rhythmic networks that underlie consciousness and coordination. We'll trace the journey from single-cell membrane dynamics to complex neural circuits, then connect these mechanisms to clinical conditions like epilepsy, multiple sclerosis, and myasthenia gravis. By mastering neurophysiology's electrical engineering, you'll understand both how the nervous system achieves its remarkable computational power and why it fails in disease.

The nervous system operates through two fundamental communication mechanisms: electrical signaling within neurons and chemical signaling between neurons. These processes occur with remarkable precision - action potentials propagate at speeds up to 120 m/s in myelinated fibers, while synaptic transmission occurs within 0.5-2 milliseconds.

📌 Remember: SPEED for myelinated fiber conduction velocity - Saltatory conduction, Propagation velocity = 6 × diameter (μm), Electrical isolation by myelin, Energy efficient, Diameter dependency (larger = faster)

Neural communication follows a hierarchical organization from molecular to systems level:

• Molecular Level (10⁻⁹ m scale)
  • Ion channel kinetics: opening/closing in microseconds
  • Neurotransmitter binding: millisecond timescales
    • Glutamate clearance: 1-2 ms from synaptic cleft
    • GABA receptor activation: <1 ms onset
• Cellular Level (10⁻⁶ m scale)
  • Action potential duration: 1-2 ms in most neurons
  • Refractory periods: absolute (1 ms), relative (2-4 ms)
    • Sodium channel inactivation: 1 ms duration
    • Potassium channel closure: 2-3 ms timeline
• Network Level (10⁻³ to 10⁻¹ m scale)
  • Synaptic integration: 10-50 ms time windows
  • Circuit oscillations: 1-100 Hz frequency ranges

The resting membrane potential of -70 mV represents a carefully maintained electrochemical gradient. This potential depends on the 3:2 Na⁺/K⁺ pump ratio, which consumes 20-25% of total brain ATP. The Goldman equation governs membrane potential, with potassium permeability dominating at rest (40x greater than sodium).

💡 Master This: The -70 mV resting potential isn't arbitrary - it represents the optimal balance between excitability and energy efficiency. Neurons more negative than -80 mV become hypoexcitable, while those more positive than -60 mV risk spontaneous firing and excitotoxicity.

Connect these electrical foundations through synaptic mechanisms to understand how individual neural events create complex behaviors and clinical presentations.

⚡ Bioelectrical Command Centers: Membrane Dynamics Mastery

Sodium Channel Kinetics drive action potential initiation with three distinct states:

• Resting State (membrane < -60 mV)
  • Activation gates: closed (voltage-dependent)
  • Inactivation gates: open (time-dependent)
    • Channel availability: 100% for activation
    • Sodium permeability: minimal (<1% of peak)
• Activation State (-55 to +30 mV)
  • Activation gates: open (responds in 0.1 ms)
  • Inactivation gates: closing (1 ms time constant)
    • Peak sodium current: 500-1000 pA per channel
    • Channel open probability: >90% at peak
• Inactivation State (+30 to -70 mV)
  • Activation gates: open but non-conducting
  • Inactivation gates: closed (blocks pore)
    • Absolute refractory period: 1-2 ms duration
    • Channel recovery: voltage and time dependent

📌 Remember: FAST for sodium channel states - Fast activation (0.1 ms), Absolute refractory when inactivated, State-dependent drug binding, Threshold at -55 mV triggers opening

• Delayed Rectifier (Kv) channels
  • Activation threshold: -40 to -20 mV
  • Kinetics: slow activation (5-10 ms), no inactivation
    • Function: action potential repolarization
    • Clinical: KCNQ mutations cause benign familial neonatal epilepsy
• A-type (KA) channels
  • Activation: -60 mV, rapid inactivation (10-100 ms)
  • Function: controls firing frequency, delays excitation
    • Clinical: reduced KA increases seizure susceptibility
• Calcium-activated (KCa) channels
  • Activation: calcium-dependent, voltage-independent
  • Subtypes: BK (big), SK (small), IK (intermediate)
    • Function: afterhyperpolarization, spike frequency adaptation

⭐ Clinical Pearl: Episodic ataxia type 1 results from KCNA1 mutations affecting Kv1.1 channels. Patients experience minutes-long ataxic episodes triggered by startle or exercise, responding to acetazolamide in >80% of cases.

Calcium Channel Classification determines synaptic strength and plasticity:

• L-type (Cav1.x) - Long-lasting, high-voltage activated
  • Threshold: -10 mV, slow inactivation (100-500 ms)
  • Location: cell bodies, dendrites, muscle
  • Function: gene transcription, excitation-contraction coupling
• N-type (Cav2.2) - Neither L nor T, presynaptic
  • Threshold: -20 mV, moderate inactivation (50 ms)
  • Location: nerve terminals, synaptic vesicle release sites
  • Clinical: ω-conotoxin target, chronic pain therapy
• P/Q-type (Cav2.1) - Purkinje cell, high-voltage
  • Threshold: -15 mV, slow inactivation (200 ms)
  • Clinical: CACNA1A mutations cause familial hemiplegic migraine, episodic ataxia type 2

💡 Master This: Calcium channel blockers show subtype selectivity - L-type blockers (nifedipine) treat hypertension but worsen heart failure, while N-type blockers (ziconotide) provide analgesia without cardiovascular effects.

Connect these channel mechanisms through action potential propagation to understand how membrane dynamics create the foundation for neural network communication.

🚀 Signal Propagation Highways: Action Potential Mastery

Action Potential Phases follow stereotyped kinetics with clinical correlations:

• Phase 0: Rapid Depolarization (0-1 ms)
  • Sodium influx: 500-fold permeability increase
  • Voltage change: -55 to +30 mV in 0.5 ms
    • Peak sodium current: 1-5 nA per neuron
    • Driving force: 120 mV (ENa - Em)
  • Clinical: Local anesthetic target phase
• Phase 1: Early Repolarization (1-2 ms)
  • Sodium inactivation: fast (τ = 1 ms)
  • Transient potassium: A-type channels activate
    • Voltage plateau: +20 to +30 mV briefly
    • Channel transition: Na+ inactivation dominates
• Phase 2: Repolarization (2-5 ms)
  • Delayed rectifier K+: major repolarizing current
  • Voltage return: +30 to -70 mV exponentially
    • Time constant: 2-3 ms in most neurons
    • Potassium efflux: restores electronegativity
• Phase 3: Afterhyperpolarization (5-15 ms)
  • Calcium-activated K+: SK and BK channels
  • Voltage undershoot: -75 to -85 mV transiently
    • Duration: determines firing frequency
    • Amplitude: 2-15 mV below resting

📌 Remember: SNAP for action potential phases - Sodium rush (depolarization), Na+ inactivation (peak), After-hyperpolarization (undershoot), Potassium efflux (repolarization)

• Node of Ranvier spacing: 1-2 mm intervals
  • Sodium channel density: 1000-3000/μm² at nodes
  • Internodal resistance: >10¹² Ω (myelin insulation)
    • Current flow: confined to nodes
    • Conduction velocity: 6 × diameter (μm) = m/s
• Myelin structure: 150-200 wraps of oligodendrocyte membrane
  • Capacitance reduction: 50-fold decrease
  • Energy savings: 30-fold less ATP consumption
    • Metabolic advantage: crucial for long axons
    • Clinical vulnerability: demyelination slows conduction

⭐ Clinical Pearl: Multiple sclerosis preferentially affects myelinated tracts, causing conduction block when core temperature rises by 0.5°C (Uhthoff's phenomenon). This explains why 80% of MS patients experience symptom worsening with fever or hot baths.

Conduction Velocity Factors determine clinical presentation patterns:

• Fiber diameter: primary determinant of velocity
  • Large fibers (>10 μm): affected first in compression
  • Small fibers (<5 μm): affected first in metabolic neuropathy
    • Diabetic neuropathy: small fiber predominance
    • Carpal tunnel: large fiber compression pattern
• Temperature effects: 2-5% change per °C
  • Hypothermia: slows conduction, prolongs reflexes
  • Hyperthermia: blocks demyelinated fibers
    • Nerve conduction studies: temperature standardization required
    • Clinical correlation: cold paresis in demyelination
• Age-related changes: 1-2% decline per decade after age 30
  • Myelin thinning: gradual velocity reduction
  • Axonal loss: amplitude reduction predominates
    • Normal aging: distal latency prolongation
    • Pathological: conduction block or severe slowing

💡 Master This: Nerve conduction velocity <40 m/s in motor fibers or <35 m/s in sensory fibers suggests demyelination, while normal velocities with reduced amplitudes indicate axonal loss. This distinction guides prognosis - demyelination recovers in weeks to months, axonal loss requires months to years.

Connect these propagation principles through synaptic transmission mechanisms to understand how electrical signals convert to chemical communication across neural networks.

🔗 Synaptic Command Networks: Chemical Signal Integration

Synaptic Transmission Cascade occurs through precisely timed molecular events:

• Calcium Influx (0.1-0.5 ms after AP arrival)
  • Channel types: N-type, P/Q-type predominant
  • Calcium concentration: 100-200 μM in active zones
    • Resting [Ca²⁺]: 50-100 nM intracellularly
    • Peak [Ca²⁺]: 10-50 μM near release sites
  • Cooperativity: 4th power relationship (Ca⁴)
• Vesicle Fusion (0.2-2 ms after calcium entry)
  • SNARE complex: synaptobrevin, syntaxin, SNAP-25
  • Release probability: 0.1-0.3 per vesicle per AP
    • Readily releasable pool: 5-20 vesicles per active zone
    • Vesicle recycling: 20-60 seconds for endocytosis
• Neurotransmitter Clearance (1-10 ms duration)
  • Diffusion: passive from synaptic cleft
  • Reuptake: active transport via specific transporters
    • Enzymatic degradation: acetylcholinesterase (ACh)
    • Glial uptake: glutamate, GABA clearance

📌 Remember: CLEAR for synaptic transmission - Calcium triggers release, Low probability per vesicle, Exocytosis via SNARE, Active zone organization, Reuptake terminates signal

• Excitatory Postsynaptic Potentials (EPSPs)
  • Amplitude: 0.1-2 mV per synapse
  • Duration: 10-50 ms (AMPA), 100-500 ms (NMDA)
    • AMPA receptors: fast, Na⁺/K⁺ permeable
    • NMDA receptors: slow, Ca²⁺ permeable, Mg²⁺ blocked
  • Summation threshold: 15-20 mV depolarization needed
• Inhibitory Postsynaptic Potentials (IPSPs)
  • Amplitude: 0.5-5 mV hyperpolarization
  • Duration: 20-100 ms (GABA-A), 200-500 ms (GABA-B)
    • GABA-A: Cl⁻ influx, fast inhibition
    • GABA-B: K⁺ efflux, slow inhibition
  • Shunting inhibition: reduces input resistance

⭐ Clinical Pearl: Benzodiazepines enhance GABA-A receptor function by increasing chloride channel opening frequency without changing single-channel conductance. This explains their dose-dependent effects: anxiolysis at low doses, sedation at moderate doses, and anesthesia at high doses.

NMDA Receptor Function enables synaptic plasticity and learning:

• Dual requirement: glutamate binding + postsynaptic depolarization
  • Glycine co-agonist: required for channel opening
  • Mg²⁺ block: voltage-dependent, removed at -30 mV
    • Coincidence detection: pre + post activity required
    • Calcium permeability: 10x higher than AMPA
• Long-term Potentiation (LTP) induction
  • Calcium threshold: >1 μM for CaMKII activation
  • Duration: hours to days with protein synthesis
    • Early LTP: 30-60 minutes, kinase-dependent
    • Late LTP: >3 hours, transcription-dependent
• Clinical significance: NMDA hypofunction in schizophrenia
  • Ketamine model: NMDA antagonist produces psychotic symptoms
  • Cognitive deficits: working memory, attention impairments
    • Treatment target: glycine transport inhibitors
    • Biomarker: mismatch negativity reduction

💡 Master This: Synaptic strength follows the Hebbian rule: "Cells that fire together, wire together." This principle underlies all forms of learning and explains why repetitive stimulation strengthens neural pathways while disuse leads to synaptic weakening and memory loss.

Connect these synaptic mechanisms through neural network oscillations to understand how individual synaptic events create coordinated brain rhythms and complex behaviors.

🌊 Neural Oscillation Networks: Rhythm and Synchrony Mastery

Brain Rhythm Classification reflects distinct functional states:

• Delta (0.5-4 Hz) - Deep sleep, unconsciousness
  • Amplitude: 100-200 μV (highest)
  • Generation: thalamocortical circuits, slow oscillations
    • Function: memory consolidation, synaptic homeostasis
    • Clinical: increased in encephalopathy, coma
• Theta (4-8 Hz) - Memory encoding, spatial navigation
  • Amplitude: 50-100 μV
  • Generation: hippocampal CA1 pyramidal cells
    • Function: working memory, episodic encoding
    • Clinical: reduced in Alzheimer's disease
• Alpha (8-13 Hz) - Relaxed wakefulness, sensory gating
  • Amplitude: 20-60 μV
  • Generation: thalamic pacemaker cells
    • Function: attention, sensory inhibition
    • Clinical: asymmetry suggests focal pathology
• Beta (13-30 Hz) - Active concentration, motor control
  • Amplitude: 10-30 μV
  • Generation: cortical interneuron networks
    • Function: cognitive processing, movement preparation
    • Clinical: excessive in anxiety, stimulant use
• Gamma (30-100 Hz) - Conscious binding, attention
  • Amplitude: 5-15 μV (lowest)
  • Generation: fast-spiking interneurons
    • Function: feature binding, consciousness
    • Clinical: reduced in schizophrenia

📌 Remember: DTABG for frequency bands - Delta (deep sleep), Theta (thinking/memory), Alpha (awake/relaxed), Beta (busy/active), Gamma (grouped/conscious)

• T-type calcium channels in thalamic neurons
  • Activation: -65 to -55 mV (hyperpolarized states)
  • Inactivation: slow (100-200 ms), voltage-dependent
    • Burst firing: 2-4 Hz during sleep
    • Tonic firing: >10 Hz during wakefulness
• Hyperpolarization-activated (Ih) channels
  • Activation: <-60 mV, slow kinetics (seconds)
  • Function: pacemaker current, rhythmogenesis
    • Sleep spindles: 11-15 Hz thalamic oscillations
    • Clinical: HCN mutations cause epilepsy
• Reticular thalamic nucleus (RTN)
  • GABA-ergic: inhibits thalamic relay nuclei
  • Connectivity: receives cortical and thalamic inputs
    • Spindle generation: RTN bursting drives spindles
    • Attention: RTN gates sensory transmission

⭐ Clinical Pearl: Sleep spindles decrease with aging and neurodegenerative diseases. Spindle density <2 per minute predicts cognitive decline in elderly patients with 85% sensitivity. Spindle frequency also slows from 13-14 Hz in young adults to 11-12 Hz in seniors.

Gamma Oscillations enable cognitive binding through interneuron synchronization:

• Parvalbumin-positive interneurons generate 40 Hz rhythms
  • Fast-spiking: >200 Hz maximum firing rate
  • Perisomatic targeting: controls pyramidal cell output
    • GABA-A kinetics: fast (1-5 ms) inhibition
    • Network synchrony: ±1 ms precision across cortical areas
• Pyramidal-interneuron gamma (PING) mechanism
  • Excitatory drive: pyramidal → interneuron
  • Inhibitory feedback: interneuron → pyramidal
    • Cycle duration: 25 ms (40 Hz)
    • Phase relationships: pyramidal leads interneuron by 5-10 ms
• Clinical correlations: gamma power and cognition
  • Attention: increased gamma in attended locations
  • Schizophrenia: reduced gamma power and synchrony
    • Auditory steady-state: 40 Hz entrainment deficits
    • Treatment: NMDA enhancement restores gamma

💡 Master This: Anesthetics suppress consciousness by disrupting gamma oscillations and thalamocortical communication. Propofol enhances GABA-A function, increasing slow waves while eliminating gamma, explaining the rapid onset of unconsciousness and amnesia.

Connect these oscillatory mechanisms through clinical applications to understand how rhythm disturbances create neurological and psychiatric symptoms.

🎯 Clinical Integration Arsenal: Neurophysiology in Practice

Electrodiagnostic Pattern Recognition enables precise localization:

• Demyelinating vs Axonal Neuropathy
  • Demyelinating: velocity <80% normal, normal amplitudes
  • Axonal: normal velocities, reduced amplitudes >50%
    • Conduction block: >20% amplitude drop without temporal dispersion
    • Temporal dispersion: duration increase >15% suggests demyelination
• Radiculopathy vs Peripheral Neuropathy
  • Radiculopathy: myotomal distribution, normal sensory conduction
  • Peripheral: nerve distribution, sensory and motor involvement
    • F-wave prolongation: proximal conduction assessment
    • H-reflex abnormalities: S1 radiculopathy sensitivity >90%
• Neuromuscular Junction Disorders
  • Myasthenia gravis: decremental response >10% at 3 Hz
  • Lambert-Eaton: incremental response >100% at 50 Hz
    • Single fiber EMG: jitter >55 μs abnormal
    • Repetitive stimulation: temperature-dependent results

📌 Remember: VAMP for electrodiagnostic patterns - Velocity (demyelination), Amplitude (axonal), Myotomal (radiculopathy), Peripheral (neuropathy)

• Temporal Lobe Epilepsy (60% of focal epilepsy)
  • Interictal: anterior temporal sharp waves
  • Ictal: rhythmic theta (5-7 Hz) onset
    • Mesial temporal: hippocampal sclerosis common
    • Lateral temporal: tumor or cortical dysplasia
• Frontal Lobe Epilepsy (20% of focal epilepsy)
  • Interictal: frontal sharp waves, often bilateral
  • Ictal: fast activity (>13 Hz), rapid generalization
    • Clinical: brief, frequent, nocturnal seizures
    • Semiology: bizarre movements, preserved awareness
• Generalized Epilepsy (30% of all epilepsy)
  • 3 Hz spike-wave: absence seizures
  • 4-6 Hz spike-wave: juvenile myoclonic epilepsy
    • Photoparoxysmal response: genetic epilepsy marker
    • Sleep deprivation: activates generalized discharges

⭐ Clinical Pearl: Benign epileptiform transients of sleep (BETS) occur in 24% of normal adults and can be mistaken for pathological sharp waves. Key distinguishing features: small amplitude (<50 μV), broad field, temporal maximum, and disappearance in deeper sleep stages.

Neurotransmitter System Targeting guides therapeutic selection:

• Dopaminergic System disorders
  • Parkinson's disease: substantia nigra degeneration
  • Treatment: L-DOPA (crosses blood-brain barrier)
    • Carbidopa: prevents peripheral L-DOPA conversion
    • Wearing-off: motor fluctuations after 3-5 years
  • Dopamine agonists: pramipexole, ropinirole
    • Impulse control: 15% develop gambling, hypersexuality
    • Sleep attacks: sudden onset sleep in 10%
• Cholinergic System enhancement
  • Alzheimer's disease: cholinergic deficit predominant
  • Acetylcholinesterase inhibitors: donepezil, rivastigmine
    • Modest benefit: 2-4 point MMSE improvement
    • Side effects: GI (nausea, diarrhea) in 30%
  • Myasthenia gravis: pyridostigmine
    • Cholinergic crisis: excessive ACh, muscle weakness
    • Edrophonium test: diagnostic but rarely used
• GABAergic System modulation
  • Epilepsy: multiple GABA enhancement strategies
  • Benzodiazepines: allosteric GABA-A enhancement
    • Tolerance: develops within weeks
    • Withdrawal: life-threatening seizures possible
  • Vigabatin: irreversible GABA-transaminase inhibition
    • Retinal toxicity: bilateral visual field defects in 30%
    • Monitoring: perimetry every 6 months

💡 Master This: Therapeutic drug monitoring is essential for antiepileptic drugs with narrow therapeutic windows. Phenytoin shows zero-order kinetics above 10 mg/L - small dose increases can cause disproportionate level rises and toxicity. Free levels are more accurate than total levels in hypoalbuminemia.

These clinical frameworks transform neurophysiological principles into diagnostic precision and therapeutic success, enabling expert-level patient care across neurological and psychiatric conditions.